Ophthalmology

Soluble interleukin 2 receptor IDs sarcoidosis in uveitis

(HealthDay)—Soluble interleukin 2 receptor (sIL-2R) has slightly better diagnostic value than angiotensin-converting enzyme (ACE) for sarcoidosis in patients with uveitis, according to a study published online Nov. 9 in ...

Ophthalmology

New RNAi treatment targets eye inflammation

Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.

Immunology

Cancer drugs could target autoimmune diseases

Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King's College London.

Diseases, Conditions, Syndromes

Adalimumab reduces inflammation in refractory pediatric uveitis

A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients ...

Ophthalmology

Diabetes drug could treat leading cause of blindness

University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world's leading causes ...

page 1 from 2